ArticleJournal of asthma and allergy2025

Economic Evaluation of Mepolizumab as Add-on Therapy to Standard Care in Severe Eosinophilic Asthma: A Cost-Effectiveness Analysis in Colombia.

Jefferson Antonio Buendia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.